Recent advances in cytogenetic characterization of multiple myeloma-Reference-Cited by-同舟云学术

Recent advances in cytogenetic characterization of multiple myeloma

Published:2018-07-03 Issue:1 Volume:41 Page:5-14
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hem

Author:

Saxe Debra¹,Seo Eul‐Ju²,Beaulieu Bergeron Melanie³⁴,Han Jin‐Yeong⁵^ORCID

Affiliation:

1. Department of Pathology and Laboratory Medicine Emory University School of Medicine Atlanta Georgia

2. Department of Laboratory Medicine College of Medicine and Asan Medical Center University of Ulsan Seoul Korea

3. Department of Pathology and Laboratory Medicine University of Ottawa Ottawa ON Canada

4. Department of Genetics Children's Hospital of Eastern Ontario Ottawa ON Canada

5. Department of Laboratory Medicine Dong‐A University College of Medicine Busan Korea

Funder

Dong-A University

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.12882

Reference60 articles.

1. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

2. Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting 2016

3. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

4. HoM AndersonKC BianchiG.Multiple myeloma: Atlas Genet Cytogenet Oncol Haematol in press.http://AtlasGeneticsOncology.org/Anomalies/MultipleMyelomaID1776.html.

5. Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine for multiple myeloma: The case for translocation (11;14);Cancer Treatment Reviews;2024-11

2. A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping;Blood Cancer Journal;2024-05-03

3. The numerous facets of 1q21⁺ in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review);Oncology Letters;2024-04-09

4. Clinical utility of 7-probe FISH panel in multiple myeloma in a resource-constrained setting: A retrospective and prospective observational study;Cancer Research, Statistics, and Treatment;2024-04

5. Cytogenetic, Clinical, Hematologic, Demographic, Immunohistochemical, and Flow Cytometry Characteristics of Patients with Plasma Cell Neoplasm in Five Years: A First Report from Iran;IRAN J MED SCI;2024